Acute Phase Reactants and Hematologic Profiles vs Blood Culture in Late Preterm Neonatal Sepsis
DOI:
https://doi.org/10.21070/ijhsm.v2i2.201Keywords:
Late Preterm Infant, Neonatal Sepsis, Blood Culture, Infant, CRPAbstract
Background: Neonatal sepsis involves physical and laboratory findings due to infection within the first 30 days of life, with preterm infants being six times more at risk than term infants due to their immature immune systems and prolonged hospitalization. Sepsis is more common in males and in developing countries. The World Health Organization estimates 5 million neonatal deaths annually, mostly in developing countries. Despite advances in neonatal care, late-onset sepsis remains a significant cause of morbidity and mortality. Aim: To evaluate the significance of acute phase reactants and hematological findings versus blood culture in diagnosing sepsis in late preterm infants. Method: A cross-sectional study of 70 neonates with suspected sepsis from January 2011 to March 2012 at Babylon Teaching Hospital. Patients were classified as having early or late-onset neonatal sepsis. Tests included blood culture, c-reactive protein, erythrocyte sedimentation rate, white blood cell, platelets, and band cells. Results: Of the 70 patients, 55.7% were male and 44.3% were female. Early sepsis was observed in 40% of patients, and late sepsis in 60%. Blood culture was positive in 25.7% of cases, with 83.3% of these in early sepsis. CRP was positive in 91.4% of patients, including 100% of early sepsis cases and 85.7% of late sepsis cases. Positive band cells were found in 45.7% of cases, with 83.3% of these having positive blood cultures. Abnormal WBC counts (<5000 or >21000) were found in 64.3% of cases. Low platelet counts (<150,000) were observed in 55.7% of patients, with 67.8% in early sepsis and 47.6% in late sepsis. Elevated ESR (>6mm/h) was seen in 91.4% of cases. Conclusion: Blood culture remains the gold standard for diagnosing sepsis, though its accuracy can be affected by antibiotic use. Combining multiple diagnostic tests improves predictive values over single tests.
Highlights:
-
Late-onset sepsis remains a major cause of neonatal morbidity and mortality.
-
CRP and ESR showed high positivity, supporting their value in early detection.
-
Blood culture is essential but benefits from combined diagnostic markers.
Keywords: Late Preterm Infant, Neonatal Sepsis, Blood Culture, Infant, CRP.
References
[1] D. Sharma, I. V. Padmavathi, S. A. Tabatabaii, and N. Farahbakhsh, “Late Preterm: A New High‑Risk Group in Neonatology,” Journal of Maternal‑Fetal & Neonatal Medicine, vol. 34, no. 16, pp. 2717–2730, 2021.
[2] K. G. Pius, E. A. Albane, B. Marie‑Paul, D. Komba, V. Ngando, and A. Eteme, “Neonatal Sepsis: Highlights and Controversies,” Journal of Pediatrics and Neonatal, vol. 4, no. 1, pp. 1–5, 2022.
[3] C. George, H. Jeffery, and M. Lahra, “Infection of Mother and Baby,” in Keeling’s Fetal and Neonatal Pathology, Elsevier, 2022, pp. 207–245.
[4] S. S. Abdel‑Razeq, “Septic Shock,” in Critical Care Obstetrics, 7th ed., Wiley, 2024, pp. 665–695.
[5] F. Cavigioli et al., “Neonatal Early Onset Sepsis (EOS) Calculator Plus Universal Serial Physical Examination (SPE): A Prospective Two‑Step Implementation of a Neonatal EOS Prevention Protocol for Reduction of Sepsis Workup and Antibiotic Treatment,” Antibiotics, vol. 11, no. 8, p. 1089, 2022.
[6] M. Van Belkum, L. Mendoza Alvarez, and J. Neu, “Preterm Neonatal Immunology at the Intestinal Interface,” Cellular and Molecular Life Sciences, vol. 77, pp. 1209–1227, 2020.
[7] O‑D. Bălălău, O‑G. Olaru, A. V. Dumitru, I. Păunică, and A. D. Stănescu, “Maternal Infections with an Increased Risk of Transmission to the Foetus: A Literature Review,” Journal of Clinical Investigative Surgery, vol. 5, no. 2, pp. 66–72, 2020.
[8] P. C. Ndagijimana, Reducing Prolonged Hospital Stay for Moderate and Late Premature Babies in Neonatal Intensive Care Unit (NICU) of Kabgayi District Hospital, Master’s thesis, Univ. of Rwanda, 2022.
[9] A. M. Nyenga, O. Mukuku, and S. O. Wembonyama, “Neonatal Sepsis: A Review of the Literature,” Theory and Clinical Practice in Pediatrics, vol. 3, pp. 94–101, 2021.
[10] N. J. Russell et al., “Patterns of Antibiotic Use, Pathogens, and Prediction of Mortality in Hospitalized Neonates and Young Infants with Sepsis: A Global Neonatal Sepsis Observational Cohort Study (NeoOBS),” PLoS Medicine, vol. 20, no. 6, p. e1004179, 2023.
[11] H. S. Naher and A. T. Al‑Sa’ady, “Review on Bacterial Etiology of Neonatal Infections,” EurAsian Journal of Biosciences, vol. 14, no. 2, pp. — (article number), 2020.
[12] G. L. Goh et al., “Risk Factors for Mortality from Late‑Onset Sepsis Among Preterm Very‑Low‑Birth‑Weight Infants: A Single‑Center Cohort Study from Singapore,” Frontiers in Pediatrics, vol. 9, p. 801955, 2022.
[13] I. O. Odabasi and A. Bulbul, “Neonatal Sepsis,” Şişli Etfal Hastanesi Tıp Bülteni, vol. 54, no. 2, pp. 142–158, 2020.
[14] D. B. Lewis, J.‑H. Weitkamp, and O. Levy, “Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection,” in Infectious Diseases of the Fetus and Newborn Infant, 8th ed., Elsevier, 2024, pp. 73–159.
[15] T. de Baat et al., “Clinical Predictors of Bacteraemia in Neonates with Suspected Early‑Onset Sepsis in Malawi: A Prospective Cohort Study,” Archives of Disease in Childhood, vol. 108, no. 5, pp. 350–356, 2023.
[16] C. S. Rosmo, “Etiology of Early‑Onset Sepsis in a Global Context – A Systematic Review,” Journal, 2022 (journal unspecified).
[17] J. Johnson, I. C. Akinboyo, and J. K. Schaffzin, “Infection Prevention in the Neonatal Intensive Care Unit,” Clinics in Perinatology, vol. 48, no. 2, pp. 413–429, 2021.
[18] G. P. Tsafaras, P. Ntontsi, and G. Xanthou, “Advantages and Limitations of the Neonatal Immune System,” Frontiers in Pediatrics, vol. 8, p. 5, 2020.
[19] M. McGovern et al., “Challenges in Developing a Consensus Definition of Neonatal Sepsis,” Pediatric Research, vol. 88, no. 1, pp. 14–26, 2020.
[20] B. A. Sullivan and K. D. Fairchild, “Vital Signs as Physiologic Markers of Neonatal Sepsis,” Pediatric Research, vol. 91, no. 2, pp. 273–282, 2022.
[21] F. B. Al Bakoush, A. E. Azab, and R. A. Yahya, “Neonatal Sepsis: Insight into Incidence, Classification, Risk Factors, Causative Organisms, Pathophysiology, Prognosis, Clinical Manifestations, Complications, Systemic Examination, and Treatment,” South Asian Research Journal of Applied Medical Sciences, vol. 5, no. 6, pp. 136–157, 2023.
[22] P.‑Y. Iroh Tam and C. M. Bendel, “Diagnostics for Neonatal Sepsis: Current Approaches and Future Directions,” Pediatric Research, vol. 82, no. 4, pp. 574–583, 2017.
[23] M. S. Niederman et al., “Initial Antimicrobial Management of Sepsis,” Critical Care, vol. 25, p. — (article number), 2021.
[24] A. L. Davis et al., “American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock,” Critical Care Medicine, vol. 45, no. 6, pp. 1061–1093, 2017.
[25] C. R. Popescu et al., “Neonatal Sepsis in Low‑Income Countries: Epidemiology, Diagnosis and Prevention,” Expert Review of Anti‑Infective Therapy, vol. 18, no. 5, pp. 443–452, 2020.
[26] D. R. Msanga, F. Parpia, E. T. Konje, A. Hokororo, and S. E. Mshana, “High Mortality among Premature Neonates with Positive Blood Culture Neonatal Sepsis in a Tertiary Hospital, Tanzania: A Call for Action,” Children, vol. 8, no. 11, p. 1037, 2021.
[27] A. Ferreira, E. Sousa, J. Freitas, M. Vieira, F. Miranda, and F. Silva, “Positive Blood Culture and Neonatal Sepsis – A Five‑Year Study,” Nascer e Crescer – Birth and Growth Medical Journal, vol. 31, no. 2, pp. 106–114, 2022.
[28] A. D. W. Widodo, P. B. D. Permana, A. Setyaningtyas, and M. R. Wahyunitisari, “Time to Positivity of Blood Culture as a Predictor of Causative Pathogens and Survival in Neonatal Sepsis: A Retrospective Cohort Study from Indonesia,” Oman Medical Journal, vol. 39, no. 1, p. e588, 2024.
[29] E. A. Morad, R. A. Rabie, M. A. Almalky, and M. G. Gebriel, “Evaluation of Procalcitonin, C‑Reactive Protein, and Interleukin‑6 as Early Markers for Diagnosis of Neonatal Sepsis,” International Journal of Microbiology, vol. 2020, art. 8889086, 2020.
[30] S. Negi, L. Bala, A. Jain, M. Joshi, and V. K. Pahuja, “Can CRP and Band Cell Be Protagonist in Neonatal Septicemia?,” Annals of International Medical and Dental Research, vol. 7, no. 2, p. 7, 2018.
[31] A. Habib, S. Raza, U. Ali, A. M. Zubairi, and E. Salim, “Diagnostic Accuracy of Serum Procalcitonin (PCT) as an Early Biomarker of Neonatal Sepsis Using Blood Culture as Gold Standard,” Journal of the College of Physicians and Surgeons Pakistan, vol. 30, no. 4, pp. 383–387, 2021.
[32] E. Saboohi, F. Saeed, R. N. Khan, and M. A. Khan, “Immature-to‑Total Neutrophil Ratio as an Early Indicator of Early Neonatal Sepsis,” Pakistan Journal of Medical Sciences, vol. 35, no. 1, p. 241, 2019.
[33] R. R. Choudhary et al., “Evaluation of Platelet and Its Indices as a Marker of Neonatal Sepsis: A Prospective Case Control Study,” International Journal of Contemporary Pediatrics, vol. 5, no. 5, pp. 1898–1903, 2018.
[34] V. Deshpande et al., “Sensitivity and Specificity of Micro ESR versus Definitive Blood Markers for Neonatal Sepsis as Screening Test in a Tertiary Care Hospital, Navi Mumbai,” Journal of Cardiovascular Disease Research, vol. 15, pp. 1267–1268, 2021.
[35] J. Jatsho, Y. Nishizawa, D. Pelzom, and R. Sharma, “Clinical and Bacteriological Profile of Neonatal Sepsis: A Prospective Hospital‑Based Study,” International Journal of Pediatrics, vol. 2020, art. 1835945, 2020.
[36] E. M. R. Shehab El‑Din, M. M. A. El‑Sokkary, M. R. Bassiouny, and R. Hassan, “Epidemiology of Neonatal Sepsis and Implicated Pathogens: A Study from Egypt,” BioMed Research International, vol. 2015, art. 509484, 2015.
[37] B. J. Stoll, “Epidemiology of Early‑ and Late‑Onset Neonatal Infections,” in Nelson Textbook of Pediatrics, 19th ed., Elsevier Saunders, 2011, pp. 633–638.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Aiub Bassim Naji, Ammer Muhssin Hadi, Akram Hamdi Muhssin, Dheyaa Aldeen Alkhateeb
This work is licensed under a Creative Commons Attribution 4.0 International License.
